Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens
Authors:
Preprint
Abstract
There is increasing recognition that the allosomes, X and Y, play an important role in health and disease beyond the determination of biological sex. A loss of the Y chromosome (LOY) occurs in most solid tumors in males and is often associated with worse survival, suggesting that LOY may give tumor cells a growth or survival advantage. We here use an expression-based continuous measure of LOY that allows us to investigate LOY in lung adenocarcinoma (LUAD) using both bulk and single-cell expression data. We find evidence suggesting that LOY affects the tumor immune environment by altering cancer/testis antigen expression and consequently facilitating tumor immune evasion, also reflected in inferred gene regulatory networks. In immunotherapy data, we further show that LOY and changes in expression of particular cancer/testis antigens are associated with response to pembrolizumab treatment and outcome. This computational study provides new insights into the mechanisms behind LOY in LUAD and a powerful biomarker for predicting immunotherapy response in LUAD tumors in males.Keywords
Funding Information
- National Cancer Institute (R35CA220523)
- National Cancer Institute (U24CA231846)
- National Cancer Institute (P50CA127003)
- National Human Genome Research Institute (R01HG011393)
- National Heart Lung and Blood Institute (P01HL114501)
- National Heart Lung and Blood Institute (T32HL007427)
- National Heart Lung and Blood Institute (K24HL171900)
- National Heart Lung and Blood Institute (K01HL166376)
- American Lung Association (LCD-821824)
This publication has 88 references indexed in Scilit:
- Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non‐small cell lung cancerCancer Innovation, 2024
- Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinomaCellular Oncology, 2023
- eXclusionarY: 10 years later, where are the sex chromosomes in GWASs?The American Journal of Human Genetics, 2023
- CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signalingMolecular and Cellular Biochemistry, 2022
- MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinomaCancer Communications, 2021
- Involvement of cytochrome P450 enzymes in inflammation and cancer: a reviewCancer Chemotherapy and Pharmacology, 2020
- Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data2020
- Spontaneous CD4+ and CD8+ T‐cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patientsEuropean Journal of Immunology, 2017
- Y chromosome loss detected by FISH in bladder cancerCancer Genetics and Cytogenetics, 1995
- Y chromosome loss and rearrangement in non‐small‐cell lung cancerInternational Journal of Cancer, 1993